Supriya Lifescience IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 17, 2022Let’s have a detailed review of the company and analytics of the Supriya Lifescience IPO release date, IPO offer price, subscription, Supriya Lifescience Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.
| Face Value | Rs 2 |
| Cash Price | Rs 265 to Rs 274 |
| Listing At | BSE, NSE |
| Min. Order Quantity | 54 Shares |
| Listing Date | Dec 28, 2021 |
| Offer for Sale | Rs 5000 Million |
| Fresh Issue | Rs 2,000 Million |
| IPO Size | Rs 7000 Million |
| Tick Size | 1 |
Supriya Lifescience IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.
Supriya Lifescience IPO – Summary
They are one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of March 31, 2021, they have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and anti-allergic.
They have consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-55% and 65-70%, respectively, of the API exports from India, between Fiscal 2017 and 2020. They were among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume
The Promoter of this company is SATISH WAMAN WAGH. The lead manager to the issue is ICICI Securities Limited, and Axis Capital Limited, and the Registrar to this issue is Link Intime India Private Limited.
Supriya Lifescience IPO Date
The opening and the closing date of the IPO of Supriya Lifescience Limited are Dec 16, 2021, and Dec 20, 2021, respectively.
Check out Related IPO Links:
| Supriya Lifescience IPO GMP |
| Supriya Lifescience IPO Allotment |
Supriya Lifescience IPO Subscription
| Day / Date | QIB | NII | RII | Total Subscription |
| 1st Day – 16th Dec | 0.00x | 0.66x | 11.84x | 2.33x |
| 2nd Day – 17th Dec | 0.53x | 2.90x | 25.38x | 5.69x |
| 3rd Day – 20th Dec | 31.83x | 161.22x | 55.75x | 71.47x |
| Shares Offered or Net Issue | 7,924,527 | 3,962,263 | 2,641,509 | 14,528,299 |
The shares subscribed by the public will be updated here.
Check Supriya Lifescience IPO LIVE Subscription
- Supriya Lifescience IPO LIVE Bid details on BSE
- Supriya Lifescience IPO LIVE Bid details on NSE
For the Latest Bid details click on the above links.
Supriya Lifescience IPO Allotment Status
Here, you can find the Allotment Status of this IPO.
Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.
Supriya Lifescience Limited IPO Listing Date
Find the dates below on basis of allotment, refund, listing, and more:
| Basis of Allotment Finalization | Dec 23, 2021 |
| Refunds Initiation | Dec 24, 2021 |
| Credit of Shares to Demat Account | Dec 27, 2021 |
| Share Listing Date | Dec 28, 2021 |
Supriya Lifescience IPO Cash Price
The face value of each share is Rs.2, but the price band of the IPO is Rs 265 to Rs 274
Supriya Lifescience IPO Equity Size
This Initial Public Issue of X Equity Shares of Rs.2 each for cash at a price of Rs 265 to Rs 274 per equity share aggregating to Rs.7000 Million.
Supriya Lifescience IPO Share Offering
Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of [●] Equity Shares of Rs.2/ each.
Issue Size: X Equity Shares of Rs.2 each, aggregating to Rs.7000 Million
Offer for Sale Size: X Equity Shares of Rs.2 each, aggregating to Rs.5,000 Million
Open Free Demat Account Now!
Supriya Lifescience IPO – Live Performance
The listing date of this IPO is Dec 28, 2021. You can check the live performance of the IPO here, only after it is listed on exchanges.
| Live IPO Performance – Supriya Lifescience Share Price |
Supriya Lifescience IPO Grey Market Premium
The Supriya Lifescience Limited IPO Grey Market Premium price is Rs 140, the Kostak rate is Rs NA and the Subject to Sauda is Rs 6000.
Supriya Lifescience IPO – Company Overview
Their pharmaceutical business is organized into domestic and export sales, according to the geographies in which they operate. In Fiscal 2021, their products were exported to 78 countries to 1,060 customers including 286 distributors.
Their customers include global pharma companies such as Syntec Do Brasil LTDA, American International Chemical Inc, and AT Planejamento E Desenvolvimento De Negocios Ltda, with whom they have a business relationship for over nine years, and Suan Farma Inc, Acme Generics LLP, Akum Drugs Ltd and Mankind Pharma Ltd with whom they have a business relationship for over four years.
Their products are approved by various international regulatory authorities such as USFDA, EUGMP, EDQM, SFDA NMPA, ANVISA, KFDA, PMDA, TGA, and Taiwan FDA. As of March 31, 2021, they have filed 11 active DMFs with USFDA and seven active CEPs with EDQM, for their API products in therapeutic areas such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and anti-allergic.
Supriya Lifescience IPO – Financial Statements
A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:
Financial Summary:
| Amount (in INR & Million) | ||||
| 30-Sep-20 | 31-Mar-21 | Mar-20 | 31-Mar-19 | |
| Total Assets | 5,041.02 | 4,458.24 | 3,364.01 | 2,530.52 |
| *Total Revenue | 2,300.61 | 3,962.21 | 3,227.13 | 2,858.62 |
| Total Expense | 1,313.94 | 2,180.70 | 2,132.62 | 2,131.01 |
| Profit After Tax | 659.59 | 1,238.28 | 733.74 | 394.24 |
Earnings per Equity Share (in Million)
| 30-Sep-20 | 31-Mar-21 | Mar-20 | 31-Mar-19 | |
| Basic & Diluted | 9.01 |
16.92
|
10.03 | 5.39 |
Supriya Lifescience IPO – Promoters
The Promoter of this company is:
- SATISH WAMAN WAGH
List of Related Parties (Key Managerial Personnel)
- Satish Waman Wagh, Chairman and Managing Director
- Smita Satish Wagh, Whole-time Director
- Saloni Satish Wagh, Whole-time Director
- Shivani Satish Wagh, Whole-time Director
- Balasaheb Gulabrao Sawant, Whole-time Director
- Kedar Shankar Karmarkar, Independent Director
Supriya Lifescience IPO – Promoters Holding
- Pre Issue Share Holding – 99.98%
- Post Issue Share Holding – %
Supriya Lifescience IPO Offer Details or Issue Details
| Particulars | No. Of Equity Shares |
| Equity Shares Offered | Up to X Equity Shares aggregating up to Rs.7000 Million |
| of which: | |
| Issue Reserved for the Market Makers | Up to [●] Equity Shares aggregating up to Rs.2,000 Million |
| Net Issue to the Public | Up to [●] Equity Shares aggregating up to Rs.5,000 Million |
| Of which: | |
| Retail Investors Portion | Not less than [●] Equity Shares |
| Other than Retail Individual Investors | Not more than [●] Equity Shares |
| Equity Shares outstanding prior to the Issue | 73,183,530 Equity Shares |
| Equity Shares outstanding after the Issue | 73,183,530 Equity Shares |
Supriya Lifescience IPO Issue Object
Their Company proposes to utilize the Net Proceeds towards funding the following objects:
1. Funding capital expenditure requirements of their Company
2. Repayment and/ or pre-payment, in full or part, of certain borrowings availed by their Company
3. General corporate purposes
Supriya Lifescience IPO – Business Strategy
- Expansion of manufacturing capabilities
- Expanding product portfolio with increasing R&D capabilities
- Increase current market presence and enter new markets
- Continue to focus on operational excellence
Supriya Lifescience IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Significant scale with a leadership position across key & niche products
- Backward integrated business model
- Advanced manufacturing and research and development capabilities
- Consistent strong financial performance due to de-risked business model
- Experienced senior management team and qualified operational personnel
The relevant quantitative factors are:
| Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
| 31-Mar-20 | 10.03 | 49.19 | 20.38 |
| 31-Mar-19 | 5.39 | 42.03 | – |
| Mar-18 | 1.19 | 15.97 | – |
Supriya Lifescience IPO: Competitive Peers
| Face Value (Rs.) | P/E | EPS (Rs.) | Return on Net Worth (%) | Total Income (Rs. in Millions) | |
| Supriya Lifescience Limited | 2 | NA | 10.41 | 33.85 | 2,679.27 |
| Listed Peers | |||||
| Solara Active Pharma Sciences Limited | 10 | 35.34 | 44.29 | 10.50 | 13,492.70 |
| Neuland Laboratories Limited | 10 | 212.42 | 12.63 | 2.28 | 7,665.97 |
| Aarti Drugs Limited | 10 | 12.89 | 60.57 | 21.67 | 18,075.71 |
| Wanbury Limited | 10 | 3.95 | 26.90 | (44.94) | 3,685.95 |
| Divis Laboratories Limited | 2 | 77.71 | 51.85 | 18.83 | 55,840.50 |
Supriya Lifescience IPO Lead Managers
| Lead Managers |
| ICICI Securities Limited
Axis Capital Limited |
Supriya Lifescience IPO Registrar to offer
| Registrar to the Offer |
| Link Intime India Private Limited C-101, 247 Park, 1st Floor, L.B.S. Marg, Vikhroli West Mumbai 400 083 Maharashtra. India Tel: +91 22 4918 6200 E-mail: supriyalife.ipo@linkintime.co.in Website: www.linkintime.co.in Contact Person: Shanti Gopalkrishnan SEBI Registration No.: INR000004058 |
Supriya Lifescience IPO – Other Details
- Statutory Auditor – Kakaria and Associates LLP, Chartered Accountants
- Legal Counsel to the Company – Khaitan & Co
- Bankers to the Company – NA
Supriya Lifescience IPO Review by Stock Brokers
| Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
| Angel Broking | 7.5/10 | 7.4/10 | 8.5/10 | 8.1/10 | 7.1/10 |
| Sharekhan | 7.2/10 | 7.1/10 | 8.6/10 | 8.1/10 | 7.2/10 |
| Kotak Securities | 7.3/10 | 7.5/10 | 8.4/10 | 8.1/10 | 7.3/10 |
| ICICI Direct | 7.3/10 | 7.3/10 | 8.7/10 | 8.1/10 | 7.1/10 |
| IIFL | 7.5/10 | 7.2/10 | 8.8/10 | 8.0/10 | 7.1/10 |
| Edelweiss | 7.5/10 | 7.4/10 | 8.4/10 | 8.3/10 | 7.2/10 |
| Zerodha | 7.4/10 | 7.1/10 | 8.5/10 | 8.1/10 | 7.0/10 |
| 5Paisa | 7.1/10 | 7.1/10 | 8.4/10 | 8.1/10 | 7.1/10 |
| Karvy | 7.4/10 | 7.3/10 | 8.2/10 | 8.1/10 | 7.1/10 |
| Motilal Oswal | 7.1/10 | 7.1/10 | 8.6/10 | 8.3/10 | 7.2/10 |
Subscribe to Supriya Lifescience IPO
Supriya Lifescience Limited IPO News
News 1 – IPO DRHP Download
News 2 – IPO RHP Prospectus Download
Supriya Lifescience IPO Review FAQs
Ques – What is the Issue Size of Supriya Lifescience IPO?
Answer – The Company is making an initial public offer of NA equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.
Ques – What is the Price band of Supriya Lifescience IPO?
Answer – The price band for this particular IPO ranges between Rs 265 to Rs 274. As far as the face value of the share is of concern, it is Rs.2 per share.
Ques – What is the Supriya Lifescience IPO Open Date?
Answer – The opening and closing dates for this IPO have been updated. The IPO is set to open on Dec 16, 2021, while the closing date is set at Dec 20, 2021.
Ques – What is the Supriya Lifescience IPO Allotment Date?
Answer – They also have the news regarding the respective allotment dates of this IPO. Basis of Allotment finalization is on Dec 23, 2021, refund initiation is on Dec 24, 2021, credit of shares is on Dec 27, 2021, and share listing date is on Dec 28, 2021.
Ques – What is the Supriya Lifescience IPO Listing Date?
Answer – Shares of this company shall be listed in the exchanges on Dec 28, 2021. The date, when the listing would be done, is stagnant on Dec 28, 2021.
Ques – Who is the Registrar of Supriya Lifescience IPO?
Answer – One of the reputed registrars is managing the issue of this IPO, i.e. Link Intime India Private Limited. Their website will help you regarding the further information you are on the lookout for.
Ques – Who is the Promoter of Supriya IPO?
Answer – Here are the promoters of this IPO – SATISH WAMAN WAGH. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
Ques – What is the GMP of Supriya Lifescience IPO?
Answer – They have obtained the GMP of this IPO and it is Rs 140. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.
Ques – Is Supriya IPO good for Investment?
Answer – They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
Ques – What is the PAT of Supriya Lifescience Ltd?
Answer – They have the information of company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2021 in Million is 1,238.28, 2020 is 733.74, 2019 is 394.24. PAT from Sep 2021 is 659.59.
Calculate your return on investment!
Asset Class
ROI (Rs.)
Profit (Rs.)
Profit (%)
IPO
Equity
Savings
Real Estate
Gold
Bonds
Fixed Deposit
Mutual Fund
Featured Topics